AESKULISA® PROTEIN S
Mexico·Clase I·III. DIAGNOSTIC AGENTS·GRIFOLS MÉXICO, S.A. DE C.V.·Registered July 16, 2019PARA LA DETERMINACIÓN CUANTITATIVA DE PROTEÍNA S TOTAL Y LIBRE EN PLASMA HUMANO CITRATADO. LA DETERMINACIÓN DE PROTEÍNA S ES UNA AYUDA EN LA ESTIMACIÓN DEL RIESGO DE TROMBOSIS.
FOR THE QUANTITATIVE DETERMINATION OF TOTAL AND FREE PROTEIN S IN CITRATE HUMAN PLASMA. THE DETERMINATION OF PROTEIN S IS AN AID IN ESTIMATING THE RISK OF THROMBOSIS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO DE PROTEÍNA S TOTAL Y LIBRE
- Trade Name (English)
- TOTAL AND FREE PROTEIN S REAGENT
- Analysis ID
- 1327R2019 SSA
- Registration Date
- July 16, 2019
- Name (Spanish)
- GRIFOLS MÉXICO, S.A. DE C.V.
- Name (English)
- GRIFOLS MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for AESKULISA® PROTEIN S (AESKULISA® PROTEIN S) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1327R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on July 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.